Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …

The quadrivalent vaccine has been shown to be safe and efficacious against HPV infection
in men. It is expected, though, that male vaccination rates will remain low. Therefore this …

Purpose. Human papillomavirus (HPV) disease and vaccines and several controversial
issues associated with vaccine administration are reviewed. Summary. HPV infection is the …

Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …

The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …

Persistent infections by carcinogenic or high-risk genotypes of human papillomavirus (HPV)
have been proved to be the cause of virtually all cervical cancer and are also associated …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

Abstract Introduction In the United States, Federally Qualified Health Centers (FQHCs) are
safety-net clinics that provide cervical cancer screening and human papillomavirus (HPV) …

Human papillomavirus (HPV) is perhaps the most common sexually transmitted infection in
the United States. There are 5.5 million new cases of HPV every year, and approximately 20 …